Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Disney, Bumble Rise Premarket; Expedia Falls

Published 02/12/2021, 08:08 AM
Updated 02/12/2021, 08:08 AM
© Reuters.

By Peter Nurse 

Investing.com -- Stocks in focus in premarket trade on Friday, February 12th. Please refresh for updates.

  • Walt Disney (NYSE:DIS) stock rose 1.9% after the entertainment giant recorded a surprise quarterly profit late Thursday, as its fast-growing streaming business outweighed the Covid-inspired damage to its theme park and cruise operations.

  • Bumble (NASDAQ:BMBL) stock rose 4.7%, continuing to move higher after the dating app company’s IPO raised $2.2 billion, pricing well above expectations. The stock gained over 60% on its debut Thursday.

  • Virgin Galactic (NYSE:SPCE) stock fell 9% after Bloomberg reported that the company's next spaceflight test has been cancelled.
  • Pfizer (NYSE:PFE) stock rose 0.2% and Moderna (NASDAQ:MRNA) stock climbed 1.7% after President Joe Biden announced that the U.S. had finished deals for 100 million additional vaccine doses from each of the two drug makers and that they would deliver new and existing orders quicker than projected.

  • Expedia (NASDAQ:EXPE) stock fell 0.5% after the online travel agency posted a bigger-than-expected quarterly loss after the bell Thursday as bookings slumped following a resurgence in Covid-19 infections and renewed lockdowns.

  • Chevron (NYSE:CVX) stock fell 0.5% and Exxon Mobil (NYSE:XOM) stock fell 0.9%, falling as oil prices headed south on demand fears.

  • Coherent (NASDAQ:COHR) stock rose 14% after the Wall Street Journal reported that electronics component maker II-VI (NASDAQ:IIVI) is planning a $6.5 billion bid for the laser maker.

  • Affirm (NASDAQ:AFRM) stock fell 5.6% after the financial technology company reported a loss of 45 cents per share in its first results since going public on Jan. 13.

  • Bausch Health (NYSE:BHC) stock rose 5.5% after influential investor Carl Icahn bought a 7.8% stake in the pharmaceutical company, according to a Securities and Exchange Commission filing. 

  • Tilray (NASDAQ:TLRY) stock fell 3.1% while Aurora Cannabis (NYSE:ACB) stock fell 7.9%, with the cannabis sector still seeing volatile trading as the week’s bid up peters out.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

 

Latest comments

Criminal pre-market activity is well underway...Can't have a loss on a Friday in the US Ponzi Scheme, greatest financial fraud in history, and biggest investment joke in the world.
Get out of Expedia and into Trip.com
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.